Emerging Strategies for Management of Endocrine Responsive Breast Cancer
30 August 2008
Intercontinental São Paulo
Alameda Santos 1123
São Paulo, Brazil
Activity Overview
On behalf of Drs. Mohammad Jahanzeb and Carlos Barrios, we are pleased to invite you the Emerging Strategies for Management of Endocrine Responsive Breast Cancer meeting in São Paulo, Brazil on 30 August 2008. During this case-based meeting, International leaders in the field will discuss clinical issues encountered daily in clinical practice. Participants will have an opportunity to interact with faculty members through interactive discussion and an audience response system.
Delegates will receive:
Roundtrip economy air or train transportation
Hotel accommodation for 29 August 2008
Faculty
Co-chairs:
Mohammad Jahanzeb, MD
Carlos Barrios, MD
Faculty:
Christian Marth, MD
Susana Campos, MD
Ricardo Marques, MD
Agenda
Scientific Agenda & Faculty
08.00–09.00
Breakfast
09.00-09.05
Welcome and Introduction
Mohammed Jahanzeb, MD Carlos Barrios, MD
09.05-09.35
Case #1: The Premenopausal Patient: A Unique Therapeutic Challenge
Christian Marth, MD
09.35-10.05
Case #2: Postmenopausal Breast Cancer Patient at High Risk of Early Recurrence:
Best Choices for Adjuvant Endocrine Therapy
Mohammad Jahanzeb, MD
10.05-10.35
Case #3: Adjuvant Endocrine Therapy for a Perimenopausal Patient: What’s
Best?
Carlos Barrios, MD
10.35-11.05
Case#4: Locally Advanced Primary Breast Cancer: Optimal Management
Christian Marth, MD
11.05-11.25
Ask the Experts-An Interactive Discussion
11.25-11.45
Break
11.45-12.15
Case #5: Optimal Management of Metastatic Disease in an Endocrine Responsive
Patient After Adjuvant Systemic Treatment
Ricardo Marques, MD
12.15-12.45
Interactive Debate: Multigene Signatures: Are They Ready for Prime Time Use?
Pro: Mohammad Jahanzeb, MD
Contra: Susana Campos, MD
12.45-13.05
Panel Discussion: Do the Results of ABCSG-12 Create a New Paradigm of Care
Regarding Adjuvant Use of Zoledronic Acid in Early Breast Cancer Treatment?
All Faculty
13.05-13.20
Break
13.20–14.00
Keynote Lunch Presentation: Future Directions in Adjuvant Systemic Therapy
for Endocrine Responsive Early Breast Cancer
